Letter to the Editor Stroke welcomes Letters to the Editor and will publish them, if suitable, as space permits. Letters must reference a Stroke published-ahead-of-print article or an article printed within the past 3 weeks. The maximum length is 750 words including no more than 5 references and 3 authors. Please submit letters typed double-spaced. Letters may be shortened or edited.
Response to Letter Regarding Article, “Asymmetric Dimethylarginine in Response to Recombinant Tissue-Type Plasminogen Activator and Erythropoietin in Acute Stroke” In their letter, Kurtoglu et al1 suggest an association of renal dysfunction and asymmetric dimethylarginine (ADMA) levels in patients with acute ischemic stroke because an association has been demonstrated in other cardiovascular diseases. Using the Spearman rank correlation, we found as well a significant negative correlation between the glomerular filtration rate and ADMA serum levels in our current study (glomerular filtration rate on admission versus ADMA day 1: r=−0.770, P
Response to Letter Regarding Article, “Asymmetric Dimethylarginine in Response to Recombinant Tissue-Type Plasminogen Activator and Erythropoietin in Acute Stroke” In their letter, Kurtoglu et al1 suggest an association of renal dysfunction and asymmetric dimethylarginine (ADMA) levels in patients with acute ischemic stroke because an association has been demonstrated in other cardiovascular diseases. Using the Spearman rank correlation, we found as well a significant negative correlation between the glomerular filtration rate and ADMA serum levels in our current study (glomerular filtration rate on admission versus ADMA day 1: r=−0.770, P
